Clik here to view.
Foundation Medicine Expands Partnership with Sequanta to Provide both Liquid...
CAMBRIDGE, Mass. & SHANGHAI Foundation Medicine, Inc., today announced that it has expanded its partnership with Sequanta Technologies Co., Ltd. (“Sequanta”) to provide genomic profiling...
View ArticleClik here to view.
ENHERTU® Approved in the EU as the First HER2 Directed Therapy for Patients...
TOKYO & MUNICH ENHERTU® (trastuzumab deruxtecan) has been approved in the European Union (EU) as a monotherapy for the treatment of adult patients with advanced non-small cell lung cancer...
View ArticleClik here to view.
AGCバイオロジクス、メディジーンの新しい細胞治療製品をサポートするTCR-T細胞サービス契約を締結
米シアトル （ビジネスワイヤ） — バイオ医薬品開発・受託製造企業（CDMO）大手のAGCバイオロジクスは、メディジーン（、FSE略称 MDG1、プライム・スタンダード）と新たなサービス契約を締結することを発表しました。同契約のもと、AGCバイオロジクスは、固形がん治療に特化した次世代治療向け製品のための自己製剤を提供し、メディジーンのIND申請と臨床試験をサポートします。...
View ArticleClik here to view.
Otsuka Pharmaceutical Announces Positive Topline Results From Two Pivotal...
TOKYO & PRINCETON, N.J. Otsuka Pharmaceutical Co., Ltd. and its U.S. subsidiary, Otsuka Pharmaceutical Development & Commercialization, Inc., today announced positive results of two, 6-week,...
View ArticleClik here to view.
Engine Biosciences Secures $27 Million Series A Extension to Advance...
SINGAPORE & REDWOOD CITY, Calif. Engine Biosciences, a company leveraging machine learning and high-throughput biology to discover and develop precision oncology medicines, today announced the...
View ArticleClik here to view.
Genome Insight Secures $23 Million in Series B-2 Funding Round
SAN DIEGO Genome Insight, a precision healthcare solutions company promoting whole-genome technology for accurate diagnosis and personalized treatment for cancer and rare disease, today announced...
View ArticleClik here to view.
Denodo、新たなプラットフォームの改良によりビジネスユーザーの生産性向上とクラウド・データレイクのコスト削減を実現
カリフォルニア州パロアルト （ビジネスワイヤ） — データ管理のリーダーであるDenodoは、本日、Denodo...
View ArticleClik here to view.
LegoChem Biosciences Selects BostonGene as Genomic Partner for First-in-Human...
WALTHAM, Mass. BostonGene, a leading provider of AI-driven, molecular and immune profiling solutions, and LegoChem Biosciences, Inc. (LCB), a clinical-stage biopharmaceutical company developing...
View ArticleClik here to view.
Parse Biosciences Extends Global Reach with India-based Spinco Biotech...
SEATTLE Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced an agreement with India-based Spinco Biotech to further extend its reach in...
View ArticleClik here to view.
BeiGene to Present at the Jefferies London Healthcare Conference
BASEL, Switzerland & BEIJING & CAMBRIDGE, Mass. BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company, today announced that the Company will participate in...
View ArticleClik here to view.
Takeda’s ADZYNMA (ADAMTS13, recombinant-krhn) Approved by U.S. FDA as the...
OSAKA, Japan & CAMBRIDGE, Mass. Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ADZYNMA (ADAMTS13, recombinant-krhn) for the prophylactic...
View ArticleClik here to view.
Sirius Therapeutics Announces Submission to Begin First Clinical Trial of...
SAN DIEGO & SHANGHAI Sirius Therapeutics today announced it has submitted an application in Australia to begin a first-in-human clinical trial of SRSD107, its next generation siRNA therapeutic...
View ArticleClik here to view.
GenScript ProBio Signs Viral Vector Manufacturing MOU With Curocell for...
SEOUL, South Korea On November 10, a global multimodality CDMO, GenScript ProBio and specialized CAR-T therapy firm Curocell signed a strategic partnership MOU for the production of viral vectors...
View ArticleClik here to view.
Genome Insight to Unveil Hong Kong Real-World Evidence on Target Enhanced...
SAN DIEGO Genome Insight, a precision healthcare solutions company advancing whole-genome technology for accurate diagnosis and personalized treatment for cancer and rare disease, will announce...
View ArticleClik here to view.
Astria Therapeutics to Present STAR-0215 Data at the 2023 World Allergy Congress
BOSTON Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunological diseases, today announced that it will share...
View ArticleClik here to view.
OliX Pharmaceuticals Announces Positive Safety Data and Preliminary Efficacy...
SUWON, South Korea OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a leading developer of RNAi therapeutics, today announced positive results from a Phase 1 study evaluating the safety and tolerability...
View ArticleClik here to view.
BioSkryb Genomics Appoints Genomics Industry Veteran Ram Laxman as Chief...
DURHAM, N.C. BioSkryb Genomics, a company transforming single-cell analysis by enabling the most complete multiomic view of the cellular ecosystem, from discovery to diagnostics, has appointed Ram...
View ArticleClik here to view.
Daiichi Sankyo Demonstrates Breadth and Depth of Oncology Portfolio Across...
BASKING RIDGE, N.J. Daiichi Sankyo (TSE: 4568) will present new clinical research across its oncology portfolio in multiple types of solid and blood cancers at the 2023 ESMO Asia Congress...
View ArticleClik here to view.
ReNAgade Therapeutics任命Paul Perreault为董事会成员
马萨诸塞州剑桥 (美国商业资讯)– 致力于释放RNA药物无限潜力的公司ReNAgade Therapeutics 今天宣布任命Paul Perreault为董事会成员，此任命自2023年12月5日起生效。Perreault先生最近担任CSL首席执行官，他在生物技术行业拥有40多年的领导经验。 ReNAgade首席执行官Amit D....
View ArticleClik here to view.
ReNAgadeセラピューティクス、ポール・ペロー氏を取締役に任命
マサチューセッツ州ケンブリッジ （ビジネスワイヤ） — RNA医薬品の無限の可能性を解き放つ企業であるReNAgadeセラピューティクス は、2023年12月5日付でポール・ペロー氏を取締役に任命したことを発表しました。ペロー氏は、直近ではCSLの最高経営責任者を務め、バイオテクノロジー業界において40年以上の指導者としての経験があります。...
View Article